The US government has reached an agreement with Kodak about the production of drugs for the American market. For organization of pharmaceutical production, the company will receive a credit in the amount of 765 million dollars, writes Fortune.
It is expected that the production of drugs in the future will amount to 30-40% of the business by Kodak. As expected, the company will be able to provide 25% of all played active pharmaceutical ingredients in the U.S. market. The production will be organized in the state of new York.